{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F6302025-late-tors-outcomes-XG_kyz00","width":444,"version":"1.0","type":"rich","title":"6.30.2025 - Late TORS Outcomes","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f0ceadbc-6d66-4d4b-b0fb-3855823b0c7a\" height=\"200\" width=\"100%\" title=\"6.30.2025 - Late TORS Outcomes\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this episode of the QuadCast where we highlight de-intensification for HPV mediated oropharyngeal squamous cell carcinoma, how the addition of radium 223 to enzalutamide improves outcomes, and much more."}